Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$45.1M |
| 2 |
Cisco
CSCO
|
+$38.8M |
| 3 |
Oracle
ORCL
|
+$37M |
| 4 |
DuPont de Nemours
DD
|
+$36.5M |
| 5 |
Eli Lilly
LLY
|
+$30.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$61.2M |
| 2 |
Wells Fargo
WFC
|
+$52.2M |
| 3 |
Amazon
AMZN
|
+$49.5M |
| 4 |
Chemours
CC
|
+$49.3M |
| 5 |
Pfizer
PFE
|
+$44.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.09% |
| 2 | Industrials | 17.32% |
| 3 | Healthcare | 15.49% |
| 4 | Consumer Discretionary | 13.3% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRS
401
DELISTED
Verso Corporation
VRS
| $3.35M | 0.05% |
175,815
-71,206
| -29% | -$1.44M |
|
402
FTI Consulting
FCN
$4.3B
| $3.31M | 0.05% |
39,483
-173,176
| -81% | -$14.2M |
|
403
Core Laboratories
CLB
$574M
| $3.29M | 0.05% |
+62,907
| New | +$3.69M |
|
404
Supernus Pharmaceuticals
SUPN
$2.67B
| $3.28M | 0.05% |
99,073
+14,808
| +18% | +$507K |
|
405
Constellation Brands
STZ
$23.2B
| $3.25M | 0.05% |
16,525
-130,600
| -89% | -$25.5M |
|
406
Commault Systems
CVLT
$5.55B
| $3.21M | 0.05% |
64,744
+21,724
| +50% | +$1.16M |
|
407
Dana Inc
DAN
$3.41B
| $3.18M | 0.05% |
159,380
-671,594
| -81% | -$12M |
|
408
VeriSign
VRSN
$25.5B
| $3.17M | 0.05% |
15,142
-59,691
| -80% | -$11.7M |
|
409
OSI Systems
OSIS
$3.41B
| $3.16M | 0.05% |
28,088
+928
| +3% | +$93.5K |
|
410
Element Solutions
ESI
$8.6B
| $3.16M | 0.05% |
+305,651
| New | +$3.22M |
|
|
ODP
411
DELISTED
ODP
ODP
| $3.15M | 0.05% |
152,860
-126,838
| -45% | -$2.87M |
|
412
HUB Group
HUBG
$2.49B
| $3.15M | 0.05% |
149,992
+66,906
| +81% | +$1.4M |
|
413
Pediatrix Medical
MD
$2.16B
| $3.15M | 0.05% |
124,662
-95,732
| -43% | -$2.57M |
|
414
Southern Company
SO
$102B
| $3.13M | 0.05% |
56,594
+2,219
| +4% | +$119K |
|
415
Innospec
IOSP
$2.31B
| $3.11M | 0.05% |
34,053
+21,443
| +170% | +$1.81M |
|
416
Carter's
CRI
$1.31B
| $3.11M | 0.05% |
31,843
-23,479
| -42% | -$2.29M |
|
417
Pilgrim's Pride
PPC
$7.68B
| $3.05M | 0.05% |
120,267
-21,698
| -15% | -$562K |
|
418
Affiliated Managers Group
AMG
$9.21B
| $3.02M | 0.05% |
32,720
+6,797
| +26% | +$667K |
|
419
BJ's Restaurants
BJRI
$1.42B
| $3M | 0.05% |
68,235
-5,059
| -7% | -$232K |
|
|
TSG
420
DELISTED
The Stars Group Inc.
TSG
| $2.95M | 0.05% |
172,785
+139,589
| +420% | +$2.48M |
|
421
AutoNation
AN
$6.6B
| $2.94M | 0.05% |
+70,069
| New | +$2.79M |
|
|
TGNA
422
DELISTED
TEGNA Inc
TGNA
| $2.94M | 0.05% |
222,100
-437,507
| -66% | -$6.74M |
|
423
RTX Corp
RTX
$283B
| $2.91M | 0.05% |
35,500
+26,961
| +316% | +$2.25M |
|
424
Manitowoc
MTW
$710M
| $2.91M | 0.05% |
163,261
-52,693
| -24% | -$874K |
|
425
Etsy
ETSY
$7.44B
| $2.9M | 0.05% |
47,340
-164,819
| -78% | -$10.8M |
|
Similar funds
Joel Greenblatt's Q2 2019 Portfolio in Review
As of Q2 2019, Joel Greenblatt held 1,366 positions worth $6.27B, down 8.2% from $6.83B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Joel Greenblatt withdrew a net $642M in Q2 2019, closing 251 positions and reducing 489 holdings. Its most notable exit was Chemours, an estimated $49.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Intuit worth $46.3M.
- Joel Greenblatt's largest Q2 2019 buy was Intuit: 177,339 shares worth $46.3M.
- Joel Greenblatt added most to Cisco in Q2 2019, an estimated $38.8M increase.
- Joel Greenblatt's biggest Q2 2019 reduction was PayPal, cutting an estimated $61.2M.
- Joel Greenblatt fully exited Chemours in Q2 2019, selling an estimated $49.3M.
- Joel Greenblatt's ten largest holdings make up 10% of its $6.27B portfolio in Q2 2019.
- Joel Greenblatt opened 206 new positions and closed 251 in Q2 2019.
- Joel Greenblatt's portfolio value fell 8.2% quarter-over-quarter to $6.27B.
Based on Gotham Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.